I R Doyle
Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis
Seymour J, Doyle I, Nakata K, Presneill J, Schoch O, Hamano E, Uchida K, Fisher R, Dunn A. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis. Thorax 2003; 58:252-7.
Mar 1, 2003Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis
Mar 1, 2003Thorax 2003; 58:252-7
Seymour J F, Doyle I R, Nakata K, Presneill J J, Schoch Otto, Hamano E, Uchida K, Fisher R, Dunn A R
Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis
Seymour J, Pain M, Langton D, Kitamura T, Nakata K, Vincent J, Doyle I, Moore P, Downie G, Schoch O, Presneill J, Dunn A. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. American journal of respiratory and critical care medicine 2001; 163:524-31.
Feb 1, 2001Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis
Feb 1, 2001American journal of respiratory and critical care medicine 2001; 163:524-31
Seymour J F, Pain M C, Langton D, Kitamura T, Nakata K, Vincent J M, Doyle I R, Moore P E, Downie G H, Schoch Otto, Presneill J J, Dunn A R